Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin

Kidney International

Volumn 64, Issue 5, 2003, Pages 1648-1652

  Bahlmann, Ferdinand H ^a   Degroot, Kirsten ^b   Duckert, Thorsten ^b   Niemczyk, Eva ^b   Bahlmann, Elisabeth ^b   Boehm, Sascha M ^b   Haller, Hermann ^b   Fliser, Danilo ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

Angiogenesis; Darbepoetin; Endothelial progenitor cells; Endothelium; Erythropoetin; Vasculogenesis

Indexed keywords

CD34 ANTIGEN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PROTEIN KINASE B; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD FLOW; CELL ACTIVITY; CELL ASSAY; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY DISEASE; MALE; PATIENT; PRIORITY JOURNAL; REGULATORY MECHANISM; STANDARD; STEM CELL;

EID: 0142187248     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00279.x     Document Type: Article

References (32)

1. PEICHEV M, NAIYER AJ, PEREIRA D, et al: Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95:952-958, 2000
2. ASAHARA T, MUROHARA T, SULLIVAN A, et al: Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967, 1997
3. ASAHARA T, MASUDA H, TAKAHASHI T, et al: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-228, 1999
4. CROSBY JR, KAMINSKI WE, SCHATTEMAN G, et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 87:728-730, 2000
5. KALKA C, MASUDA H, TAKAHASHI T, et al: Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97:3422-3427, 2000
6. TAKAHASHI T, KALKA C, MASUDA H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5:434-438, 1999
7. SCHATTEMAN GC, HANLON HD, JIAO C, et al. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 106:571-578, 2000
8. EDELBERG JM, TANG L, HATTORI K, et al. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ Res 90:E89-E93, 2002
9. KAWAMOTO A, GWON HC, IWAGURO H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103:634-637, 2001
10. KOCHER AA, SCHUSTER MD, SZABOLCS MJ, et al: Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7:430-436, 2001
11. VASA M, FICHTLSCHERER S, AICHER A, et al: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89:E1-E7, 2001
12. HILL JM, ZALOS G, HALCOX JP, et al: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593-600, 2003
13. CARLINI RG, DUSSO AS, OBIALO CI, et al: Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells. Kidney Int 43:1010-1014, 1993
14. HALLER H, CHRISTEL C, DANNENBERG L, et al: Signal transduction of erythropoietin in endothelial cells. Kidney Int 50:481-488, 1996
15. GOLDMAN SA, NEDERGAARD M: Erythropoietin strikes a new cord. Nat Med 8:785-787, 2002
16. SUTHERLAND DR, ANDERSON L, KEENEY M, et al: The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 5:213-226, 1996
17. TEPPER OM, GALIANO RD, CAPLA JM, et al: Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106:2781-2786, 2002
18. VOYTA JC, VIA DP, BUTTERFIELD CE, et al: Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 99:2034-2040, 1984
19. JACKSON CJ, GARBETT PK, NISSEN B, et al: Binding of human endothelium to Ulex europaeus I-coated Dynabeads: Application to the isolation of microvascular endothelium. J Cell Sci 96:257-262, 1990
20. BOMMAKANTI RK, VINAYAK S, SIMONDS WF: Dual regulation of Akt/protein kinase B by heterotrimeric G protein subunits. J Biol Chem 275:38870-38876, 2000
21. CAMERON JS: European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 14(Suppl 2):61-65, 1999
22. JUUL SE, YACHNIS AT, CHRISTENSEN RD: Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum Dev 52:235-249, 1998
23. FLAMME I, RISAU W: Induction of vasculogenesis and hematopoiesis in vitro. Development 116:435-439, 1992
24. LLEVADOT J, MURASAWA S, KUREISHI Y, et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 108:399-405, 2001
25. DIMMELER S, AICHER A, VASA M, et al: HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108:391-397, 2001
26. DIMMELER S, ZEIHER AM: Akt takes center stage in angiogenesis signaling. Circ Res 86:4-5, 2000
27. DRUEKE TB: Aspects of cardiovascular burden in pre-dialysis patients. Nephron 85(Suppl 1):9-14, 2000
28. METIVIER F, MARCHAIS SJ, GUERIN AP, et al. Pathophysiology of anaemia: Focus on the heart and blood vessels. Nephrol Dial Transplant 15(Suppl 3):14-18, 2000
29. SILVERBERG DS, WEXLER D, SHEPS D, et al: The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized controlled study. J Am Coll Cardiol 37:1775-1780, 2001
30. HEESCHEN C, AICHER A, LEHMANN R, et al: Erythropoietin is a potent physiological stimulus for endothelial progenitor cell mobilization. Blood 102:1340-1346, 2003
31. CELIK M, GOKMEN N, ERBAYRAKTAR S, et al: Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA 99: 2258-2263, 2002
32. CERAMI A: Beyond erythropoiesis: Novel applications for recombinant human erythropoietin. Semin Hematol 38:33-39, 2001